Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation-Reference-Cited by-同舟云学术

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

Published:2009-11-06 Issue:2 Volume:23 Page:205-212
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Niemeier Leo A,Dabbs David J,Beriwal Sushil,Striebel Joan M,Bhargava Rohit

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2009159.pdf

Reference43 articles.

1. Sengupta S, Jordan VC . Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance. Adv Exp Med Biol 2008;630:206–219.

2. Prat A, Baselga J . The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat Clin Pract Oncol 2008;5:531–542.

3. Keefe DL . Trastuzumab-associated cardiotoxicity. Cancer 2002;95:1592–1600.

4. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659–1672.

5. Tan AR, Swain SM . Therapeutic strategies for triple-negative breast cancer. Cancer J 2008;14:343–351.

Cited by 331 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge-based machine learning for predicting and understanding the androgen receptor (AR)-mediated reproductive toxicity in zebrafish;Environment International;2024-09

2. Ex vivo model of breast cancer cell invasion in live lymph node tissue;2024-07-22

3. Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC);Indian Journal of Surgical Oncology;2024-01-15

4. Research Progress on New Adjuvant Treatment Strategies and Molecular Typing of Triple-Negative Breast Cancer;Advances in Clinical Medicine;2024

5. Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?;Clinical Breast Cancer;2023-12